01513 LIVZON PHARMA
Trading Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 2.15X | Oper Margin | 24.5% |
|---|---|---|---|
| LT Debt/Equity | 10.7% | Net Margin | 17.5% |
| Total Debt/Equity | 28.4% | Return on Equity | 14.9% |
| Price/Book | 1.85X | Return on Assets | 8.4% |
| (HKD 29.900) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | 2,191.98 | 2,153.31 | 2,140.83 | 2,171.84 | 2,035.26 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +1.8 | +0.6 | -1.4 | +6.7 | +39.7 |
| Earnings Per Share (HKD) | 2.382 | 2.318 | 2.29 | 2.322 | 2.174 |
| Earnings Per Share Growth (%) | +2.8 | +1.2 | -1.4 | +6.8 | +39.5 |
| Dividend Per Share (HKD) | 1.199 | 1.482 | 1.744 | 1.512 | 1.506 |
| P/E* (X) | 12.55 | 12.90 | 13.06 | 12.88 | 13.75 |
| Yield (%) | 4.01 | 4.96 | 5.83 | 5.06 | 5.04 |
| Dividend Share (%) | 50.33 | 63.95 | 76.16 | 65.10 | 69.26 |
| Book NAV (HKD) | 16.177 | 16.752 | 16.630 | 16.959 | 15.208 |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-12-15 21:40:20
Latest Result
| (RMBMn) | 2025-09 | 2024-09 | Chg* (%) | 2023-09 |
| Cover Period (mths) | 9 | 9 | NA | 9 |
|---|---|---|---|---|
| Turnover | 9,116 | 9,082 | +0.4 | 9,655 |
| Operating Result | 2,465 | 2,298 | +7.3 | 1,940 |
| Associates | 45.883 | 18.289 | +150.9 | 47.376 |
| Profit Before Taxation | 2,497 | 2,303 | +8.4 | 1,970 |
| Taxation | 366.29 | 356.963 | +2.6 | 345.789 |
| Profit /( Loss) After Taxation | 2,130 | 1,946 | +9.5 | 1,624 |
| Minority Interests | 376.154 | 273.161 | +37.7 | 22.766 |
| Net Profit | 1,754 | 1,673 | +4.8 | 1,602 |
| Earnings Per Share () | 2.1413 | 2.0044 | +6.8 | 1.8447 |
| Announcement Date | 2025-10-23 | 2024-10-23 | NA | 2023-10-24 |
* Annualised
Last Update Time: 2025-12-15 21:40:25
